Omeprazole: Inhibiting the Final Common Pathway to Acid Secretion - The Acid Pump
Omeprazole is the first agent in a new therapeutic advance class the proton or acid pump inhibitors which represents a significant therapeutic advance in the treatment of acid related diseases. Omeprazole reduces gastric acid secretion at its source – the acid pump of the parietal cell, thereby offe...
Saved in:
Main Author: | A.B.R. Thomson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1989-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1989/463572 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proton Pump Inhibitor Omeprazole Alters the Spiking Characteristics of Proteinoids
by: Panagiotis Mougkogiannis, et al.
Published: (2025-01-01) -
Influence of Food on the Bioavailability of an Enteric-Coated Tablet Formulation of Omeprazole 20 mg Under Repeated Dose Conditions
by: ABR Thomson, et al.
Published: (1997-01-01) -
Omeprazole for Refractory Gastroesophageal Reflux Disease during Pregnancy and Lactation
by: John K Marshall, et al.
Published: (1998-01-01) -
Inhibition of Gastric Acid Secretion by Unfractionated and Low Molecular Weight Heparins in the Rat
by: Omar M.E. Abdel Salam, et al.
Published: (2006-01-01) -
Omeprazole and Ranitidine in the Prevention of Relapse in Patients with Duodenal Ulcer Disease
by: K Lauritsen, et al.
Published: (1999-01-01)